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THE discovery that many strainis of staphylococci produce a toxini (Neisser and XVNlechsberg, 19011; Kraus anid Pibream, 19062; Parker, 19243; and Burnet, 19294) has thrown fresh light on the problem of the treatment of staphylococcal lesions.
From staphylococcal toxin, Panton, Valentine, and Dix (1931)5 successfully prepared staphylococcal toxoid.
In 1933 Parish6 found that staphylococcal toxoid was innocuous to laboratory animals and was an efficient immunizing agent, causing an inicrease in the circulating antibody. Parish, O'Meara, and Clarke7 published the results of further investigations in 1934 . They found that the sera of numerous laboratory animals ancd human subjects contained appreciable amounts of natural anti-toxin.
Staphylococcal toxoid w^as first used clinically in the treatment of staphylococcal lesions by Panton and Valentine (1932) 8 , and by Dolmani (1933 rhe cases have been classified inlto four groups accor(linlg to the clinical result obtained. These groups are: "Recovered," "Markedly Improved," "Improved,"
and "Unaltered."
Those classified as recoverecd were the patienits whose lesions completely disappeared during the course of treatment. They, were inot regarded as cured until their condition had remained perfectlyr satisfactory for at least six months after the conclusion of treatment. In two cases of furunculosis a certaini degree of imlprovement took place durinig the course of treatment, but althoughl treatmenit was contilLuedi thex madle no further progress. \V"hell, howesever, treatimienit was stopped, they imiale a quick recovery.
'I[iis effect lias also beeni niotedI by AMUrray (1935),11 and(i he sulgg>ests as an exp)lanation that the staphyIlocoCCus hias producudci a degree of toxemieniawhich it takes soniwe timne for the circulating aniti-toxini to overcome.
Since infection with the staphllococcus is almilost Utniversal, it is nlot unlikely that a great dleal of minlor ill-lhealthi should be due to the toxic effects of its products. Ihlat this is prohbable is shon\wn by the inarked improvement in general health which often occurs during0, a Course of injections of staphylococcal toxoid.
METHOD OF I REATMENT.
'I he preparation of staphylococcal toxoid use(I was that supplied by I)urroughs, VelCome & to. It iS supplie(d in txo streigtlths, one teni times stroniger than the other. P'atients were grenerally given a cotirse of six to eight inijections, beginning with a (lose of O).1 or (0.2 c.c. of thle icHiIte toxoidl. '[he injections xere g,iven initramIuscularly, at weeklv interx-als, aned the doses were increase(I progressively according, to whether reactionis followed their administration or niot. Murraly and Dolman9 both recomiimendel an initial close of (3.5 c.c. of dilute toxoicl. 'I'his we have found to he too strong' an initial close, as in several of our cases it (gave rise to a imiarked -eneral (distl-bance. \We finl(l that 'er simall (loses give rise to nlo ot her (listiu-rbanice thianla shlight soreniess at the sea-t of injectioll.
['he course of injectionis given in most cases was (3.2, (3.5, andi (0.75 cc.. of the dilute toxoidI, followed by (3.1, (3.2, and (3.4 of the strong toxoid. In some cases this plan ( oul(l not be followed beCMiuse of thc marked general reactionis w-hich occurred in these patienits even whlenl smiall (loses xwere gixven. Con secquentlx treatmernt by the smliall doses toleratedl hadl to be conitinuedi oxer a loniger periodl, up to niineteeni closes having beeni given in a few inistances. 'I'lis prolon-ged( imiethodl of treatmlielnt was also adopted ini those patietits xvhose lesions were slow in improving. In both types of (ase the rcstilts obtalined were satisfactorx.
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The In six cases an exacerbation of the local lesion folloNwed the first one or two injections.
EFFECT OF THE INOCULATION 0I, STAPHYLOCOCCAL TOXOII)
UPON THE CIRCULATING AkNTI-TOXIN.
The total number of cases treated and followevc up was sixty-eight. In almost all cases the amount of circulating anti-toxin in the blood was estimated before treatmenit. Estimations were carried out on ninety-five sera taken from patients before treatment was beguni, and( the average amount of aniti-toxin present in these sera vas found to be one intertnationial unit. The method used for this estimation was that dlevised by Parish, O'Meara, andl Clarke' in 1934. It consists in the titration of the amount of anti-toxini present in a sertum, the result being expresse(d in terms of international tunits. (Parish-persotnal The result shown in the above table is in accordance with Murray's observation that four doses of toxoid increase the initial value of the circulating anti-toxin almost eightfold. The figures given are the averages calculated from these sixtyeight cases. From this table it may be deduced that the increase of circulating anti-toxin is not affected by the type or situation of the staphylococcal infection. Also, the increase in the circulatinig anti-toxin bears no relationship to the amount of toxoid given.
As regards the production of anti-toxin, it was also noted tllat two main types of response could be distinguished. Some patients ac(uire aniti-toxin very slowly, reach a comparatively low titre (three units), and lose their acquired anti-toxini equally slowly. On the other hand, some respond quickly, reach a high titre in a short time (up to thirty-eight units has been noted), and lose their accluiredl antitoxin almost as quickly as they produce it. Clinically, the members of the first group seem to have somewhat better results than those of the seconcl group, but the numbers are not large enough to allow of definite coniclusions being drawtn. On the whole, there is no relationship betNween the anti-toxin produced au(I the clinical result, as is showvn in Table V. The effect of the prolonged injection of toxoid was notecd in twenty-three cases. Frequent estimations of the anti-toxic content of the blood of these patients Nere carried out. In nine of them a continuous increase of circulating anti-toxin was producecl, but in the remaining fourteen there was either no change or an actual fall in the anti-toxic content of the blood. TIhe average fall observe(d was from eleven units to three units. It was found that the anti-toxic titre of the bloocd always falls wlhein treatment is stoppecl, but it seldom or never reaches its original level, and, indeed, selclom goes below% two or three units in amount.
In those cases liable to recurrences, the estimation of the atnti-toxic coIntenlt of the bloodl is useful, because it eniables us to determine if and wvhen a furth-er course of treatment is advisable. It also serves as a guide in the treatment of those cases which neecl a small dose every two or three -weeks to keep them free from lesions.
'VACCINE I REATMENT.
Almost all the patients who came for treatment witlh staphylococcal toxoi(d lhadl had previous courses of vaccines, either stock or autogenous. In most of these cases vaccine treatment was quite without results; in a few it -was responsible for a temporary recovery, but was without effect on being trie(d a second time.
A possible explanation of the occasional success of vaccine therapy may be found in the observation made by Burnet (1930) , 13 anid confirmiied cby Parislh, OM'.cara, and Clarke,7 that the toxins pro(luced by dlifferenit strains of staphylococcus aureus vary in potency. If, therefore, the straini of staphylococcus aurcus used to make the vaccine is a highly toxigenic one, that may account for its success vhenLi use(l in vaccine therapy.
With regard to the effect of vaccine therapy on the amount of circulating antitoxin in the blood, it was found that the average amount present in the bloods of 255 all those wlho had hal vaccinies was 0.89 uinits, while the average amount present in the bloods of tlhose} who hadl been treated 'with aitogenlous vaccines was twXo units.
Inoculation by staphylococcal toxoid marks a distinct advance in the treatment of staphylococcal lesions, but muich further wZork remains to be (lonle in the investigationi of other products of the staphylococcus. Evidenice is accunmulating to show that there is more than one toxin produced by the staphylococcus, and also tllat this organism produces other substances which are coincerned in infection and immunity. I'he polyvalency of the staphylococcal toxins may account for some of the failures in treatment which are at present inexplicable.
SUMMARY.
